Editing Kaopectate (section)

==Ingredients==
The active ingredient in Kaopectate has changed since its original creation. Originally, [[kaolinite]] was used as the [[adsorbent]] and [[pectin]] as the [[emollient]]. [[Attapulgite]] (a type of absorbent [[clay]]) replaced the kaolinite in the 1980s, but was banned by the U.S. [[Food and Drug Administration]] in a ruling made in April 2003.  As a consequence, since 2004, [[bismuth subsalicylate]] has been used as the active ingredient in U.S. marketed products.<ref>[https://web.archive.org/web/20090709172044/http://www.fda.gov/downloads/Drugs/DrugSafety/MedicationErrors/ucm080666.pdf FDA Safety Report, ''Drug Topics'', April 19, 2004]</ref>  In Canada, McNeil Consumer Healthcare continues to market Kaopectate using [[attapulgite]] as the active ingredient. However, Kaopectate was recalled in July 2021 in Canada because it may contain arsenic and lead beyond acceptable limits.<ref>{{Cite web|url=https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76131r-eng.php|title = Amended: Children's Kaopectate Suspension Product Recall (2021-07-02)|date = 28 July 2021}}</ref>

As of 2020, the US rights to Kaopectate are owned by Arcadia Consumer Healthcare (formerly Kramer Laboratories).<ref name="pringle">Sarah Pringle, [https://www.pehub.com/avista-to-make-3-7-times-its-money-with-sale-of-arcadia-consumer-healthcare/ "Avista to Make 3.7 Times its Money with Sale of Arcadia Consumer Healthcare,"] PE Hub, August 9, 2021.</ref>